Capital Fund Management S.A. Novavax Inc Call Options Transaction History

Capital Fund Management S.A.

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$10.71 - $17.11 $184,212 - $294,292	17,200 Added 48.86%	52,400 $661,000
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $136,928 - $738,144	35,200 New	35,200 $445,000
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $37,920 - $60,593	-7,900 Reduced 4.86%	154,700 $742,000
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $1.12 Million - $1.61 Million	-165,100 Reduced 50.38%	162,600 $1.18 Million
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $916,458 - $1.31 Million	-137,400 Reduced 29.54%	327,700 $2.43 Million
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $1.33 Million - $2.88 Million	-230,500 Reduced 33.14%	465,100 $3.22 Million
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $1.97 Million - $5.58 Million	222,700 Added 47.09%	695,600 $7.15 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $5.54 Million - $23.2 Million	304,200 Added 180.32%	472,900 $8.61 Billion
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $3.68 Million - $7.63 Million	101,400 Added 150.67%	168,700 $8.68 Million
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $3.19 Million - $6.53 Million	45,700 Added 211.57%	67,300 $4.96 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $1.12 Million - $1.7 Million	6,300 Added 41.18%	21,600 $4.48 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $1.85 Million - $3.94 Million	15,300 New	15,300 $3.25 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.